Advanced Screening
38,833 companies across 80 countries
| Company⇅ | Ticker↑ | Wright Quality⇅ | Market Cap⇅ | Date⇅ | Country⇅ |
|---|---|---|---|---|---|
| ZK Pelagonija AD Food, Beverage & Tobacco | ZPKO | LDD2 | $13M | 10/26/2026 | 🌐Macedonia |
| Zephyrus Wing Energies Ltd. Utilities | ZPRS | LDD0 | $546M | 10/26/2026 | |
| Zapata Quantum, Inc. Software & Services | ZPTA | LLD4 | $140M | 10/26/2026 | |
| Soilbuild Construction Group Ltd. Capital Goods | ZQM | LAC5 | $253M | 10/26/2026 | |
| ZREMB CHOJNICE S.A. Capital Goods | ZRE | LBC0 | $30M | 10/26/2026 | |
| Zscaler, Inc. Software & Services | ZS | AAD3 | $42.5B | 10/26/2026 | |
| Z Squared Inc. Software & Services | ZSQR | DBD1 | $219M | 10/26/2026 | |
| ZeroStack Corp Pharmaceuticals & Biotechnology | ZSTK | LLD0 | $68M | 10/26/2026 | |
| ZTEST Electronics Inc. Computers & Peripherals | ZTE | LAA5 | $12M | 10/26/2026 | |
| Z-Tech (India) Ltd. Capital Goods | ZTECH | LBC13 | $63M | 10/26/2026 | |
| Zotefoams plc Materials | ZTF | DBC15 | $319M | 10/26/2026 | |
| Zitopek a.d. Food, Beverage & Tobacco | ZTPK | LAC0 | $37M | 09/11/2026 | |
| Zoetis, Inc. Class A Pharmaceuticals & Biotechnology | ZTS | ABA12 | $33.5B | 10/26/2026 | |
| Zublin Immobilien Holding AG Real Estate | ZUBN | LAD2 | $201M | 10/26/2026 | |
| Vincenzo Zucchi S.p.A. Consumer Durables & Apparel | ZUC | LDD1 | $11M | 10/26/2026 | |
| ZUE S.A. Transportation | ZUE | LBD0 | $69M | 10/26/2026 | |
| Zuger Kantonalbank AG Banks | ZUGER | CCD8 | $3.9B | 10/26/2026 | |
| Zug Estates Holding AG Class B Real Estate | ZUGN | CBD2 | $1.4B | 10/26/2026 | |
| Zumiez Inc. Retailing | ZUMZ | DDD0 | $210M | 10/26/2026 | |
| Zur Shamir Holdings Ltd. Insurance | ZUR | LCD11 | $248M | 10/26/2026 | |
| Zura Bio Limited Class A Pharmaceuticals & Biotechnology | ZURA | DBD0 | $341M | 10/26/2026 | |
| Zurich Insurance Group Ltd Insurance | ZURN | ABB8 | $110.3B | 10/26/2026 | |
| Zignago Vetro SpA Materials | ZV | DBA0 | $631M | 10/26/2026 | |
| Zevia PBC Class A Food, Beverage & Tobacco | ZVIA | LBD0 | $92M | 10/26/2026 | |
| Zevra Therapeutics, Inc. Pharmaceuticals & Biotechnology | ZVRA | DAD2 | $566M | 10/26/2026 |